Positive correlation of galanin with glucose in type 2 diabetes

Diabetes Care

Volumn 28, Issue 3, 2005, Pages 759-760

  Legakis, Ioannis ^a,c   Mantzouridis, Timos ^b   Mountokalakis, Theodoros ^b  

^a Henry Dynan Hospital   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Henry Dynan Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GALANIN; HUMANS; MALE; MIDDLE AGED; POSTMENOPAUSE; REFERENCE VALUES;

EID: 14644439855     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.3.759     Document Type: Article

References (3)

1. Vrontakis ME: Galanin: a biologically active peptide (Review). Curr Drug Targets CNS Neurol Disord 1:531-541, 2002
2. Holst JJ, Bersani M, Hvidberg A, Knigge U, Christiansen E, Madsbad S, Harling H, Kofod H: On the effects of human galanin in man. Diabetologia 36:653-657, 1993
3. Bauer FE, Zintel A, Kenny MJ, Calder D, Ghatei MA, Bloom SR: Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 97:260-264, 1989